Effect of Zinc Supplementation on Duration of Hospitalization in Tanzanian Children Presenting with Acute Pneumonia
62020 fmt089.pdf (230.7Kb)
Access StatusFull text of the requested work is not available in DASH at this time ("dark deposit"). For more information on dark deposits, see our FAQ.
MetadataShow full item record
CitationFataki, M. R., R. R. Kisenge, C. R. Sudfeld, S. Aboud, J. Okuma, S. Mehta, D. Spiegelman, and W. W. Fawzi. 2013. “Effect of Zinc Supplementation on Duration of Hospitalization in Tanzanian Children Presenting with Acute Pneumonia.” Journal of Tropical Pediatrics 60 (2): 104–11. https://doi.org/10.1093/tropej/fmt089.
AbstractBackground: Zinc supplementation prevents incident pneumonia in children; however, the effect for pneumonia treatment remains unclear. Methods: A randomized, double-blind, placebo-controlled trial of zinc supplements (daily 25 mg) adjunct to antibiotic treatment of radiology-confirmed acute pneumonia was conducted among hospitalized children (6-36 months) in Dar es Salaam, Tanzania. Results: The trial was stopped early due to low enrollment, primarily owing to exclusion of children outside the age range and >3 days of prior illness. Among children enrolled (n = 94), zinc supplementation indicated no beneficial effect on the duration of hospitalization (IRR: 0.69; 95% CI 0.45-1.06; p = 0.09) or the proportion of children who were hospitalized for <3 days (RR: 0.85; 95% CI: 0.57-1.25; p = 0.40) or <5 days (RR: 1.01; 95% CI: 0.83-1.23; p = 0.92) (IRRs and RRs >1.0 favor zinc). CONCLUSIONS: Although underpowered, this randomized trial provided no evidence for a beneficial effect of zinc supplementation adjunct to antibiotics for hospitalized children.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:41384688
- SPH Scholarly Articles